» Articles » PMID: 38102300

Elucidation of Site-Specific Ubiquitination on Chaperones in Response to Mutant Huntingtin

Overview
Publisher Springer
Date 2023 Dec 15
PMID 38102300
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's disease (HD) is one of the prominent neurodegenerative diseases, characterized by the progressive decline of neuronal function, due to the accumulation and aggregation of misfolded proteins. Pathological progression of HD is hallmarked by the aberrant aggregation of the huntingtin protein (HTT) and subsequent neurotoxicity. Molecular chaperones (heat shock proteins, HSPs) play a pivotal role in maintaining proteostasis by facilitating protein refolding, degradation, or sequestration to limit the accumulation of misfolded proteins during neurotoxicity. However, the role of post-translational modifications such as ubiquitination among HSPs during HD is less known. In this study, we aimed to elucidate HSPs ubiquitin code in the context of HD pathogenesis. In a comprehensive proteomic analysis, we identified site-specific ubiquitination events in HSPs associated with HTT in HD-affected brain regions. To assess the impact of ubiquitination on HSPs during HD, we quantified the abundance of ubiquitinated lysine sites in both the rat cortex/striatum and in the mouse primary cortical neurons. Strikingly, we observed highly tissue-specific alterations in the relative ubiquitination levels of HSPs under HD conditions, emphasizing the importance of spatial perturbed post-translational modifications (PTMs) in shaping disease pathology. These ubiquitination events, combined with other PTMs on HSPs, are likely to influence the phase transitions of HTT. In conclusion, our study uncovered differential site-specific ubiquitination of molecular chaperones and offers a comprehensive view of the intricate relationship between protein aggregation, and PTMs in the context of Huntington's disease.

References
1.
Shiber A, Breuer W, Brandeis M, Ravid T . Ubiquitin conjugation triggers misfolded protein sequestration into quality control foci when Hsp70 chaperone levels are limiting. Mol Biol Cell. 2013; 24(13):2076-87. PMC: 3694792. DOI: 10.1091/mbc.E13-01-0010. View

2.
Labbadia J, Morimoto R . The biology of proteostasis in aging and disease. Annu Rev Biochem. 2015; 84:435-64. PMC: 4539002. DOI: 10.1146/annurev-biochem-060614-033955. View

3.
Li Y, Gu J, Wang C, Hu J, Zhang S, Liu C . Hsp70 exhibits a liquid-liquid phase separation ability and chaperones condensed FUS against amyloid aggregation. iScience. 2022; 25(6):104356. PMC: 9127583. DOI: 10.1016/j.isci.2022.104356. View

4.
Alberti S, Hyman A . Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol. 2021; 22(3):196-213. DOI: 10.1038/s41580-020-00326-6. View

5.
Lackie R, Maciejewski A, Ostapchenko V, Marques-Lopes J, Choy W, Duennwald M . The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. Front Neurosci. 2017; 11:254. PMC: 5433227. DOI: 10.3389/fnins.2017.00254. View